M
Makoto Kuroda
Researcher at Asahikawa Medical College
Publications - 14
Citations - 349
Makoto Kuroda is an academic researcher from Asahikawa Medical College. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 1, co-authored 1 publications receiving 16 citations.
Papers
More filters
Journal ArticleDOI
Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2
Ryuta Uraki,Maki Kiso,Shun Iida,Masaki Imai,Emi Takashita,Makoto Kuroda,Peter Halfmann,Samantha Loeber,Tadashi Maemura,Seiya Yamayoshi,Seiichiro Fujisaki,Zhongde Wang,Mutsumi Ito,Michiko Ujie,Kiyoko Iwatsuki-Horimoto,Yuri Furusawa,R. Wright,Zhenlu Chong,Seiya Ozono,Atsuhiro Yasuhara,Hiroshi Ueki,Yuko Sakai-Tagawa,Rongxiu Li,Yanan Liu,Deanna Larson,Michiko Koga,Takeya Tsutsumi,Eisuke Adachi,Makoto Saito,Shinya Yamamoto,Masao Hagihara,Keiko Mitamura,Tetsuro Sato,Masayuki Hojo,Shin-ichiro Hattori,Kenji Maeda,Riccardo Valdez,Pamela E. Bennett-Baker,Zijin Chu,Dawson Davis,Theresa Kowalski-Dobson,Ashley Eckard,Carmen Gherasim,Wolf Gremel,Kathy Lindsey,David M Manthei,A. Meyers,Julio Zuniga Moya,Aaron Rico,Emily Stoneman,Victoria Le Blanc,Savanna Sneeringer,Lauren Warsinske,Moe Okuda,Jurika Murakami,C. Duong,Sucheta Godbole,Daniel C. Douek,Ken Maeda,Shinji Watanabe,Aubree Gordon,Norio Ohmagari,Hiroshi Yotsuyanagi,Michael S. Diamond,Hideki Hasegawa,Hiroaki Mitsuya,Tadaki Suzuki,Yoshihiro Kawaoka +67 more
TL;DR: In this article , the authors evaluated the replicative ability and pathogenicity of authentic infectious BA.2 isolates in immunocompetent and human ACE2-expressing mice and hamsters.
Posted ContentDOI
Characterization and antiviral susceptibility of SARS-CoV-2 Omicron/BA.2
Yoshihiro Kawaoka,Ryuta Uraki,Maki Kiso,Shun Iida,Masaki Imai,Emi Takashita,Makoto Kuroda,Peter Halfmann,Samantha Loeber,Tadashi Maemura,Seiya Yamayoshi,Seiichiro Fujisaki,Zhongde Wang,Mutsumi Ito,Michiko Ujie,Kiyoko Iwatsuki-Horimoto,Yuri Furusawa,R. Wright,Zhenlu Chong,Seiya Ozono,Atsuhiro Yasuhara,Hiroshi Ueki,Yuko Sakai,Rongxiu Li,Yanan Liu,Deanna Larson,Michiko Koga,Takeya Tsutsumi,Eisuke Adachi,Makoto Saito,Shinya Yamamoto,Shohei Matsubara,Masao Hagihara,Keiko Mitamura,Tetsuro Sato,Masayuki Hojo,Shin-ichiro Hattori,Kenji Maeda,Moe Okuda,Jurika Murakami,C. Duong,Sucheta Godbole,Daniel C. Douek,Shinji Watanabe,Norio Ohmagari,Hiroshi Yotsuyanagi,Michael S. Diamond,Hideki Hasegawa,Hiroaki Mitsuya,Tadaki Suzuki +49 more
TL;DR: Findings suggest that the replication and pathogenicity of BA.2 is comparable to that ofBA.1 in rodents and that several therapeutic monoclonal antibodies and antiviral compounds are effective against Omicron/BA.2 variants.
Journal ArticleDOI
Characterization of SARS-CoV-2 Omicron BA.4 and BA.5 isolates in rodents
Ryuta Uraki,Peter Halfmann,Shun Iida,Seiya Yamayoshi,Yuri Furusawa,Maki Kiso,Mutsumi Ito,Kiyoko Iwatsuki-Horimoto,Sohtaro Mine,Makoto Kuroda,Tadashi Maemura,Yuko Sakai-Tagawa,Hiroshi Ueki,Rongxiu Li,Yanan Liu,Deanna Larson,Shuetsu Fukushi,Shinji Watanabe,Ken Maeda,Andrew Pekosz,Ahmed Kandeil,Richard J. Webby,Zhongde Wang,Masaki Imai,Tadaki Suzuki,Yoshihiro Kawaoka +25 more
TL;DR: In this article , the authors evaluated the replicative ability and pathogenicity of BA.4 and BA.5 isolates in wild-type Syrian hamsters, human ACE2 (hACE2) transgenic hamsters and hACE2 transgenic mice.
Journal ArticleDOI
Characterization of the SARS-CoV-2 B.1.621 (Mu) variant
Peter Halfmann,Makoto Kuroda,Tammy Armbrust,James Theiler,Ariane Balaram,Gage K. Moreno,Molly A. Accola,Kiyoko Iwatsuki-Horimoto,Riccardo Valdez,Emily Stoneman,Katarina M. Braun,Seiya Yamayoshi,Elizabeth D Somsen,John J. Baczenas,Keiko Mitamura,Masao Hagihara,Eisuke Adachi,Michiko Koga,Matthew T. McLaughlin,William M. Rehrauer,Masaki Imai,Shinya Yamamoto,Takeya Tsutsumi,Makoto Saito,Thomas C. Friedrich,Shelby L. O’Connor,David H. O’Connor,Aubree Gordon,Bette T. Korber,Yoshihiro Kawaoka +29 more
TL;DR: Reduced neutralizing antibody titers against the SARS-CoV-2 B. 1.1.621 (Mu) variant were observed, suggesting the immune response to the first infection is adequate to provide protection against a subsequent infection with the B.1., and hamsters could not be efficiently re-challenged with this variant.
Journal ArticleDOI
HLA antigens in husband-wife pairs with trophoblastic tumor.
TL;DR: No paternal and maternal HLA antigen was demonstrated to be associated with the tumor and Histocompatibility between patient and husband was not responsible for tumor growth.